NAD+ injections and IV therapy in Denver: compare the product and the bill

Start with the ingredient and the route

NAD+ is the coenzyme; nicotinamide riboside, or NR, is a precursor. The manufacturer identifies Niagen Plus as NR chloride and distinguishes it from oral Tru Niagen supplements. Manufacturer product explanation.

The table separates names that can appear in the same wellness category. Its purpose is to help identify an offer, not to choose a route for you. Matching an ingredient name is only the first check: the formulation and route still need to match the question you are asking.

If two replies use different terms, ask each provider to rewrite the description in the same format: ingredient, formulation, route, location. Leave the comparison unfinished until the replies can be placed side by side without guessing.

Denver advertisements worth clarifying

These are public descriptions, not confirmations that a clinician will offer a particular service to a particular person. Read across each row before comparing it with another. Clinic location and mobile coverage answer different logistical questions, and a published menu can still leave the final preparation or price unresolved.

The amounts below identify advertised menu items only. They are not recommended doses. All examples were checked November 5, 2026.

Use the rows to make a shortlist of unanswered questions rather than a league table. A provider with more published detail is easier to investigate, but disclosure alone does not establish better care. Conversely, an unpublished price should remain unknown until you receive a written answer; another provider’s number cannot fill that gap.

The Lafayette guide addresses a different regional question: how to investigate an NR shot request when the documented local offers and a Boulder lead do not describe the same service.

Compare the visit you would actually attend

An ingredient-and-route match lets you ask practical questions without assuming that two visits are interchangeable. Ask how the appointment is organized, who assesses suitability, who administers treatment, and who remains available during it. Request the expected time commitment for the proposed visit rather than borrowing a duration from a different service.

For example, imagine that one reply describes an infusion appointment and another describes an injection visit. A shorter advertised appointment would answer a scheduling question. It would not, by itself, answer whether the product meets your goal, whether the evidence applies, or how follow-up works. Keep the scheduling preference separate from the clinician’s assessment.

Our IV and injection comparison can help organize that conversation. Ask what would happen if the plan changed after assessment: would the appointment be postponed, a different service discussed, or a charge still apply? Having that answer before committing helps you evaluate the offer even if no treatment ultimately occurs.

Mobile service and online evaluation need different questions

A mobile visit describes where care occurs. An online evaluation describes how a conversation with a clinician may begin. Neither phrase, on its own, tells you which medicine is proposed, who supplies it, or who takes responsibility after the appointment. Ask for those details in the service description instead of inferring them from the booking format.

For a home visit, request confirmation of the exact address and the requested route together. Ask who will attend, how privacy and suitability of the setting are assessed, and whom to contact if there is a problem during or after the visit. These are questions for the provider; this review has not evaluated a home setup.

For an online starting point, clarify whether payment covers an assessment, a service reservation, or a prescription pathway subject to a clinical decision. Ask what happens financially if the requested treatment is not appropriate. The useful comparison is the responsibility and support attached to each step, not just the convenience of starting from home.

Turn a menu item into a complete written quote

Onus LoHi has a generic $250 starting card. Its ingredient-specific NAD+ menu lists a 250 mg IV at $275 standard or $195 member, and a 250 mg IM at $150 or $105. Location card; NAD+ menu.

The Niagen menu’s $297.50 headline is its member 250 mg IV price; the standard figure is $425. Niagen menu.

These November 5, 2026 examples show why a headline cannot stand in for a matched quote. Membership dues, conditions and the full visit total remain questions. Do not turn the examples into a Denver market range or compare different ingredients by price per milligram.

The complete-cost guide offers another way to arrange the bill. Keep the provider’s answer beside the advertised item so an apparent discount can be checked against the same service and payment commitment.

Read a study for the question it actually tested

Grant and colleagues’ 2019 pilot involved 11 men: eight received NAD+ IV and three were controls. It followed plasma and urine metabolism over a short observation period, not lasting clinical benefit. It did not test IM or subcutaneous shots. Read the primary study.

Reyna and colleagues’ 2026 retrospective IV comparison covered 14 clinic records, with no placebo or matched control and short follow-up. Restore Hyper Wellness funded the work and employed the authors; Niagen Biosciences donated NR. These preliminary observations do not establish injection safety or superiority. Read the study and disclosures.

A useful evidence question has a specific proposed treatment and a specific desired outcome. Ask the clinician which research addresses both, and where their explanation depends on extrapolation. A description of a biological pathway can help explain an idea without demonstrating that a particular visit produces a worthwhile change.

Write down what remains uncertain rather than converting uncertainty into a promised result. If an explanation changes from a patient outcome to a laboratory measurement, ask how the two are connected and what evidence supports that connection.

Check the preparation and the people responsible

FDA says compounded drugs lack FDA approval and are not reviewed before marketing for safety, effectiveness or quality. Facility registration is not approval of the drug. FDA compounding explanation.

FDA’s sterile-ingredient notice discusses unsuitable food-grade NAD+ and reports reactions consistent with excessive endotoxins. It makes no finding about these listed clinics and does not establish a blanket ban. FDA notice.

Ask for the dispensing pharmacy, the exact proposed preparation, and a contact who can explain its sourcing. We have not inspected the products or assigned pharmacies behind these visits. The pharmacy-checking guide helps separate product questions from the clinic’s general description.

Bring your health questions to the evaluating clinician and request an explanation of the follow-up plan in ordinary language. Use the safety discussion guide to organize concerns. A complete answer should make clear who handles medical questions and who handles billing; those responsibilities need not sit with the same person.

Decide what still needs an answer

Before narrowing the list, try describing each proposed visit in one sentence without using a promotional benefit: the ingredient, route, setting, complete quote and responsible care team. If the sentence contains an assumption, turn that assumption into your next question. A clear description makes it easier to recognize when an offer changes.

Keep a dated copy of the written reply and ask the clinician what information would change their assessment. You do not need to choose a service merely because you have compared it. If your search extends beyond the city, the Colorado directory provides geographic context while each local service still needs its own confirmation.

Nearby places and geographic context

The map uses 2025 Census Gazetteer reference points. These are communities, not verified clinic locations. Distances are straight-line estimates from Denver; they do not show driving routes or treatment availability.

Questions and answers